Skip to main content
Livermore
Livermore
ZHEN

D. E. Shaw & Co., Inc.

SEC CIK
0001009207
Latest filing
Aug 14, 2026

ALLO holding history

Allogene Therapeutics, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ALLO overviewAll 13F holders of ALLOFull Q2 2026 holdings

Shares (Q2 2026)
4,710,735
Value
$9.80M
% of portfolio
<0.1%
Quarters held
19
Since Q2 2021
Holdings of ALLO by D. E. Shaw & Co., Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20264,710,735$9.80M<0.1%+1,946,959+70.4%AddedHolders
Q1 20262,763,776$6.74M<0.1%+1,480,805+115.4%AddedHolders
Q4 20251,282,971$1.76M<0.1%+819,073+176.6%AddedHolders
Q3 2025463,898$575.2K<0.1%+463,898NewHolders
Q1 20250$00.0%−54,517−100.0%Sold outHolders
Q4 202454,517$116.1K<0.1%−35,808−39.6%ReducedHolders
Q3 202490,325$252.9K<0.1%−149,930−62.4%ReducedHolders
Q2 2024240,255$559.8K<0.1%+44,477+22.7%AddedHolders
Q1 2024195,778$875.1K<0.1%+120,138+158.8%AddedHolders
Q4 202375,640$242.8K<0.1%−48,598−39.1%ReducedHolders
Q3 2023124,238$393.8K<0.1%−151,610−55.0%ReducedHolders
Q2 2023275,848$1.37M<0.1%−236,828−46.2%ReducedHolders
Q1 2023512,676$2.53M<0.1%−147,511−22.3%ReducedHolders
Q4 2022660,187$4.15M<0.1%+220,492+50.1%AddedHolders
Q3 2022439,695$4.75M<0.1%+156,004+55.0%AddedHolders
Q2 2022283,691$3.23M<0.1%−701,412−71.2%ReducedHolders
Q1 2022985,103$8.97M<0.1%+455,288+85.9%AddedHolders
Q4 2021529,815$7.91M<0.1%+507,107+2,233.2%AddedHolders
Q3 202122,708$584.0K<0.1%−179,555−88.8%ReducedHolders
Q2 2021202,263$5.28M<0.1%+202,263NewHolders